Haijing Wu
- Immunology top 1%
- T-cell and B-cell Immunology 52
- Immune Cell Function and Interaction 44
- Atherosclerosis and Cardiovascular Diseases 15
- Immunotherapy and Immune Responses 9
- Psoriasis: Treatment and Pathogenesis 8
- Rheumatology top 0.5%
- Systemic Lupus Erythematosus Research 46
- Cancer Research top 2%
- MicroRNA in disease regulation 9
- Dermatology top 2%
- Molecular Biology top 5%
-
- Monoclonal and Polyclonal Antibodies Research 12
- Journals
- Nature (1 paper)Journal of Clinical Investigation (2 papers)Nature Communications (3 papers)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Haijing Wu
118 papers receiving 3.9k citations
Hit Papers
Peers
Comparison fields: 5 of 120
- Immunology 2.0k
- Rheumatology 1.0k
- Cancer Research 663
- Dermatology 258
- Molecular Biology 1.5k
Countries citing papers authored by Haijing Wu
This map shows the geographic impact of Haijing Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Haijing Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Haijing Wu more than expected).
Fields of papers citing papers by Haijing Wu
This network shows the impact of papers produced by Haijing Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Haijing Wu. The network helps show where Haijing Wu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Haijing Wu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | Cold and hot tumors: from molecular mechanisms to targeted therapybreakdown → | 2024 | 174 |
| 3 | 2024 | 5 | |
| 4 | 2024 | 1 | |
| 5 | 2023 | 12 | |
| 6 | 2023 | 7 | |
| 7 | 2023 | 2 | |
| 8 | 2022 | 6 | |
| 9 | 2022 | 43 | |
| 10 | 2021 | 19 | |
| 11 | 2021 | 15 | |
| 12 | 2021 | 34 | |
| 13 | 2021 | 56 | |
| 14 | 2021 | 15 | |
| 15 | 2020 | 46 | |
| 16 | 2020 | 34 | |
| 17 | 2020 | 20 | |
| 18 | 2018 | 67 | |
| 19 | 2018 | 31 | |
| 20 | 2016 | 45 |
About Haijing Wu
Haijing Wu is a scholar working on Immunology, Rheumatology and Cancer Research, having authored 120 papers that have together received 4.0k indexed citations. Recurring topics across this work include T-cell and B-cell Immunology (52 papers), Systemic Lupus Erythematosus Research (46 papers), Immune Cell Function and Interaction (44 papers), Atherosclerosis and Cardiovascular Diseases (15 papers), Monoclonal and Polyclonal Antibodies Research (12 papers), MicroRNA in disease regulation (9 papers), Immunotherapy and Immune Responses (9 papers) and Psoriasis: Treatment and Pathogenesis (8 papers). The work is most often cited by research in Immunology (2.0k citations), Rheumatology (1.0k citations) and Cancer Research (663 citations). Haijing Wu has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Ming Zhao, Qianjin Lu, Qianjin Lu, Christopher Chang, Yongjian Chen, Lina Tan, Hai Long, Di Long, Christopher Chang and Duo Li. Their work appears in journals such as Nature, Journal of Clinical Investigation and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.